Clinical Trials at Dartmouth Hitchcock Medical Center
As of August 2026, 46 paid clinical trials are recruiting at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire. Active studies at this site cover conditions such as Acute Myeloid Leukemia, Breast Cancer and Epilepsy. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
46 clinical trials at Dartmouth Hitchcock Medical Center
·Clear filters·A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis
Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Neuropathy (Small Fiber Predominant, SFN)
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Computer Guided Microwave Liver Ablation
Study Evaluating the Safety and Efficacy of an ECM Hydrogel for the Treatment of Anorectal Fistulas
TF-CBT for Autistic Youth Pilot Implementation - Open Pilot
Phentermine's Impact on Treatment in Teens
PREVENT ALL ALS Study
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
Subcortical Arousal in Perceptual Awareness
Gastrointestinal Response of Pediatric Cystic Fibrosis Patients on Mediterranean Diet
ASSESS ALL ALS Study
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients
Effects of Social Feedback on Intracranial EEG
Once Daily Intrapleural Enzyme Therapy in Complicated Parapneumonic Effusion or Empyema
EIM Via the Myolex mScan as an ALS Biomarker
A Study of Tetrathiomolybdate (TM) Plus Capecitabine
Evaluating a Strategy to Improve Pre-Anesthesia Care Discussions (My Anesthesia Choice-Hip Fracture)
TRAIL Study: Feasibility and Pilot
Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
Quality of Pediatric Resuscitation in a Multicenter Collaborative
PEDI Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcus Study
Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
Common conditions studied in Lebanon
- Acute Myeloid Leukemia (6 active studies)
- Breast Cancer (6 active studies)
- Epilepsy (6 active studies)
- Carcinoma, Non-Small-Cell Lung (5 active studies)
- Ulcerative Colitis (5 active studies)
- Non-Small Cell Lung Cancer (4 active studies)
Leading research sponsors in Lebanon
- Dartmouth-Hitchcock Medical Center
- National Cancer Institute (NCI)
- NRG Oncology
- Children's Oncology Group
- Alliance for Clinical Trials in Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Lebanon?
There are approximately 254 recruiting clinical trials in Lebanon, New Hampshire listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Lebanon pay participants?
Most recruiting trials in Lebanon compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Lebanon?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Lebanon?
The most common conditions under active study in Lebanon include Acute Myeloid Leukemia (6), Breast Cancer (6), Epilepsy (6), Carcinoma, Non-Small-Cell Lung (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Lebanon?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Lebanon on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Lebanon?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Lebanon?
Recruiting research sites in Lebanon include Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Dartmouth-Hitchcock Medical Center, Dartmouth Hitchcock Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Lebanon right now?
The largest active categories in Lebanon are Cancer & tumors (120), Neurology & pain (16), Cardiovascular (8). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.